A maior rede de estudos do Brasil

10 pág.
37  Candidíase

Pré-visualização | Página 6 de 6

33. Powderly WG. Fungal infections: Diagnosis and Mana-
gement in patients with HIV disease. HIV Clinical Mana-
gement 6:1999. www.medscape.com/Medscape/HIV/Clinical
34. Revankar SG, Dib OP, Kirkpatrick WR et al. Clinical
evaluation and microbiology of oropharyngeal infection due
to fluconazole-resistant Candida in human immuno-
deficiency virus infected patients. Clin Infect Dis 1998;
35. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes
WE, Edwards JE. Practice guidelines for the treatment of
candidiasis. Clin Infect Dis 2000; 30:662-78.
36. Sullivan DJ, Westerneng TJ, Haynes KA et al. Candida
dubliniensis sp. nov.: phenotypic and molecular characte-
rization of a novel species associated with oral candidosis in
HIV-infected individuals. Microbiology 1995; 141:1507-21.
37. Uzun O, Anaissie E. Problems and controversies in the
management of hematogenous candidiasis. Clin Infec Dis
1996; 22:S95-S101.
38. Valdez H, Gripshover BM, Slata RA, Lederman MM.
Resolution of azole-resistant oropharyngeal candidiasis after
initiation of potent combination antiretroviral therapy. AIDS
1998; 12:538.
39. Walsh TJ, Pappas P, Winston D et al. Voriconazole compared
with liposomal amphotericim B for empirical antifungal
therapy in patients with neutropenia and persistent fever. N
Engl J Med 2002; 346:225-234.

Crie agora seu perfil grátis para visualizar sem restrições.